Skip to main content
Livermore
Livermore
ZHEN

Two Sigma Advisers, LP

SEC CIK
0001478735
Latest filing
Aug 14, 2026

FOLD holding history

Amicus Therapeutics, Inc. in every 13F filed by Two Sigma Advisers, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of FOLD by Two Sigma Advisers, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−590,676−100.0%Sold outHolders
Q4 2025590,676$8.41M<0.1%+245,300+71.0%AddedHolders
Q3 2025345,376$2.72M<0.1%−551,200−61.5%ReducedHolders
Q2 2025896,576$5.14M<0.1%−136,700−13.2%ReducedHolders
Q1 20251,033,276$8.43M<0.1%+921,300+822.8%AddedHolders
Q4 2024111,976$1.05M<0.1%+52,000+86.7%AddedHolders
Q3 202459,976$640.5K<0.1%−23,700−28.3%ReducedHolders
Q2 202483,676$830.1K<0.1%+59,100+240.5%AddedHolders
Q1 202424,576$289.5K<0.1%+24,576NewHolders
Q3 20230$00.0%−235,676−100.0%Sold outHolders
Q2 2023235,676$2.96M<0.1%−201,000−46.0%ReducedHolders
Q1 2023436,676$4.84M<0.1%−82,200−15.8%ReducedHolders
Q4 2022518,876$6.34M<0.1%−209,500−28.8%ReducedHolders
Q3 2022728,376$7.60M<0.1%+112,000+18.2%AddedHolders
Q2 2022616,376$6.62M<0.1%−15,200−2.4%ReducedHolders
Q1 2022631,576$5.98M<0.1%−224,000−26.2%ReducedHolders
Q4 2021855,576$9.88M<0.1%+503,500+143.0%AddedHolders
Q3 2021352,076$3.36M<0.1%−659,400−65.2%ReducedHolders
Q2 20211,011,476$9.75M<0.1%−542,300−34.9%ReducedHolders
Q1 20211,553,776$15.4M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.